Novel ADC Designs Drive Improved Clinical Outcomes

1:02 pm - Wednesday 10th March 2027

  • Update on clinical progress for next generation ADCs, IKS014 and IKS03
  • Differentiation through ADC design to address competitive landscape
  • ADC innovation paving the way for novel payloads 

Speakers:

Chief Scientific Officer
Iksuda Therapeutics